Principal Financial Group’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.19M | Buy |
629,826
+535
| +0.1% | +$5.16K | ﹤0.01% | 1448 |
|
|
2026
Q1 | $4.67M | Buy |
629,291
+12,382
| +2% | +$130K | ﹤0.01% | 1651 |
|
|
2025
Q4 | $7.25M | Sell |
616,909
-6,850
| -1% | -$73.9K | ﹤0.01% | 1468 |
|
|
2025
Q3 | $4.82M | Sell |
623,759
-14,524
| -2% | -$102K | ﹤0.01% | 1599 |
|
|
2025
Q2 | $4.67M | Sell |
638,283
-1,128
| -0.2% | -$9.1K | ﹤0.01% | 1602 |
|
|
2025
Q1 | $6.07M | Buy |
639,411
+16,562
| +3% | +$207K | ﹤0.01% | 1494 |
|
|
2024
Q4 | $10.3M | Buy |
622,849
+18,455
| +3% | +$287K | 0.01% | 1287 |
|
|
2024
Q3 | $8.91M | Sell |
604,394
-26,000
| -4% | -$407K | ﹤0.01% | 1343 |
|
|
2024
Q2 | $8.74M | Sell |
630,394
-31,665
| -5% | -$449K | 0.01% | 1329 |
|
|
2024
Q1 | $10.4M | Sell |
662,059
-2,242
| -0.3% | -$34.6K | 0.01% | 1282 |
|
|
2023
Q4 | $10.7M | Sell |
664,301
-22,966
| -3% | -$376K | 0.01% | 1252 |
|
|
2023
Q3 | $8.45M | Sell |
687,267
-37,787
| -5% | -$562K | 0.01% | 1313 |
|
|
2023
Q2 | $11.7M | Sell |
725,054
-57,187
| -7% | -$942K | 0.01% | 1176 |
|
|
2023
Q1 | $13.6M | Sell |
782,241
-9,077
| -1% | -$129K | 0.01% | 1099 |
|
|
2022
Q4 | $7.31M | Buy |
791,318
+2,464
| +0.3% | +$23K | 0.01% | 1401 |
|
|
2022
Q3 | $6.79M | Buy |
788,854
+5,564
| +0.7% | +$55.3K | 0.01% | 1373 |
|
|
2022
Q2 | $6.38M | Sell |
783,290
-63,760
| -8% | -$609K | ﹤0.01% | 1466 |
|
|
2022
Q1 | $10.3M | Sell |
847,050
-6,212
| -0.7% | -$131K | 0.01% | 1357 |
|
|
2021
Q4 | $29.1M | Sell |
853,262
-7,609
| -0.9% | -$298K | 0.02% | 702 |
|
|
2021
Q3 | $41.5M | Buy |
860,871
+27,306
| +3% | +$1.26M | 0.03% | 504 |
|
|
2021
Q2 | $37.7M | Sell |
833,565
-18,195
| -2% | -$806K | 0.02% | 561 |
|
|
2021
Q1 | $41.1M | Buy |
851,760
+38,309
| +5% | +$1.99M | 0.03% | 499 |
|
|
2020
Q4 | $43.8M | Buy |
813,451
+7,414
| +0.9% | +$335K | 0.03% | 423 |
|
|
2020
Q3 | $29.7M | Sell |
806,037
-31,132
| -4% | -$1.16M | 0.03% | 515 |
|
|
2020
Q2 | $25.9M | Buy |
837,169
+35,844
| +4% | +$993K | 0.02% | 539 |
|
|
2020
Q1 | $22.1M | Sell |
801,325
-32,935
| -4% | -$987K | 0.02% | 513 |
|
|
2019
Q4 | $24.4M | Sell |
834,260
-53,652
| -6% | -$1.28M | 0.02% | 661 |
|
|
2019
Q3 | $17M | Buy |
887,912
+5,798
| +0.7% | +$136K | 0.02% | 888 |
|
|
2019
Q2 | $19.4M | Buy |
882,114
+68,243
| +8% | +$1.5M | 0.02% | 789 |
|
|
2019
Q1 | $16.7M | Buy |
813,871
+761,137
| +1,443% | +$13.2M | 0.02% | 910 |
|
|
2018
Q4 | $665K | Buy |
52,734
+40,936
| +347% | +$610K | ﹤0.01% | 1867 |
|
|
2018
Q3 | $181K | Buy |
+11,798
| New | +$163K | ﹤0.01% | 2182 |
|
|
2017
Q3 | – | Sell |
-11,509
| Closed | -$103K | – | 2230 |
|
|
2017
Q2 | $103K | Sell |
11,509
-10,655
| -48% | -$84.6K | ﹤0.01% | 2183 |
|
|
2017
Q1 | $175K | Buy |
22,164
+545
| +3% | +$4.44K | ﹤0.01% | 2100 |
|
|
2016
Q4 | $186K | Buy |
21,619
+11,276
| +109% | +$96.6K | ﹤0.01% | 2103 |
|
|
2016
Q3 | $85K | Hold |
10,343
| – | – | ﹤0.01% | 2115 |
|
|
2016
Q2 | $83K | Hold |
10,343
| – | – | ﹤0.01% | 2102 |
|
|
2016
Q1 | $70K | Buy |
+10,343
| New | +$68.1K | ﹤0.01% | 2108 |
|
|
2015
Q3 | – | Sell |
-14,785
| Closed | -$80K | – | 2210 |
|
|
2015
Q2 | $80K | Buy |
+14,785
| New | +$76.2K | ﹤0.01% | 2148 |
|
|
2014
Q2 | – | Sell |
-16,194
| Closed | -$56K | – | 2277 |
|
|
2014
Q1 | $56K | Sell |
16,194
-154
| -0.9% | -$577 | ﹤0.01% | 2249 |
|
|
2013
Q4 | $59K | Hold |
16,348
| – | – | ﹤0.01% | 2265 |
|
|
2013
Q3 | $49K | Buy |
+16,348
| New | +$46.1K | ﹤0.01% | 2252 |
|
Other funds holding NEO
GIP
HCA
Principal Financial Group's NEO Position: Q2 2026 in Review
Principal Financial Group increased its NeoGenomics (NEO) stake by 0.09% in Q2 2026, buying an estimated $5.16K and bringing the position to 629,826 shares worth $9.19M. The position accounts for ﹤0.01% of the portfolio, ranked #1448.
Principal Financial Group first reported a position in NEO in Q3 2013 and has held it in 42 quarters since. The position peaked at $43.8M in Q4 2020. 95 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- Principal Financial Group held 629,826 shares of NeoGenomics worth $9.19M as of Q2 2026.
- Principal Financial Group bought 535 NeoGenomics shares in Q2 2026, an estimated $5.16K.
- NeoGenomics made up ﹤0.01% of Principal Financial Group's portfolio in Q2 2026, its #1448 holding.
- Principal Financial Group first reported a position in NeoGenomics in Q3 2013 and has held it in 42 quarters since.
- Principal Financial Group's NeoGenomics position peaked at $43.8M in Q4 2020.
- 95 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.